![Huw Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Huw Jones
Amministratore Delegato presso THERACRYF PLC
Patrimonio netto: 34 205 $ in data 30/06/2024
Profilo
Huw Jones is currently the Chief Executive Officer & Director at TheraCryf Plc.
Previously, he held positions as the Chief Executive Officer & Director at Chronos Therapeutics Ltd.
and as the Non-Executive Chairman at Sinclair Pharma UK Ltd.
He also served as a Non-Executive Director at Ardana Plc, OBN (UK) Ltd., and Ixaka Ltd.
Additionally, he was the President at CV Therapeutics, Inc. Dr. Jones obtained a doctorate degree from the University of Birmingham.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
THERACRYF PLC
0.75% | 05/04/2024 | 3 184 793 ( 0.75% ) | 34 205 $ | 30/06/2024 |
Posizioni attive di Huw Jones
Società | Posizione | Inizio |
---|---|---|
THERACRYF PLC | Amministratore Delegato | 01/10/2020 |
Chronos Therapeutics Ltd.
![]() Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Presidente | - |
Ixaka Ltd.
![]() Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - |
OBN (UK) Ltd.
![]() OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Huw Jones
Società | Posizione | Fine |
---|---|---|
Sinclair Pharma UK Ltd.
![]() Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Presidente | 01/01/2006 |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Presidente | - |
Ardana Plc
![]() Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Amministratore Delegato | - |
Formazione di Huw Jones
University of Birmingham | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
THERACRYF PLC | Health Services |
Aziende private | 6 |
---|---|
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Ardana Plc
![]() Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
Sinclair Pharma UK Ltd.
![]() Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Commercial Services |
OBN (UK) Ltd.
![]() OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Commercial Services |
Chronos Therapeutics Ltd.
![]() Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Ixaka Ltd.
![]() Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Huw Jones